- ￥6768
- AntibodySystem
- 0.31-5 μg/mL
- 0.156 μg/ml
- France
- KDB95803
- 2025年07月11日
9 年钻石会员
企业认证
相关产品推荐更多 >
未包被人转铁蛋白受体1(TFR1)酶联免疫吸附测定试剂盒 | Uncoated Human TFR1(Transferrin Receptor 1) ELISA Kit
￥5200
人可溶性白细胞分化抗原CD40配体(sCD40L)酶联免疫吸附测定试剂盒 | Human sCD40L(Soluble Cluster of Differentiation 40 Ligand) ELISA Kit
￥2300未包被大鼠肿瘤坏死因子α(TNF-α)酶联免疫吸附测定试剂盒 | Uncoated Rat TNF-α(Tumor Necrosis Factor Alpha) ELISA Kit
￥4800大鼠纤溶酶原激活物抑制因子1(PAI1)酶联免疫吸附测定试剂盒 | Rat PAI1(PlasminogenActivator Inhibitor 1) ELISA Kit
￥2300未包被小鼠γ干扰素诱导单核细胞因子(MIγ/CXCL9)酶联免疫吸附测定试剂盒 | Uncoated Mouse MIγ/CXCL9(Monocyte Interferon Gamma Inducing Factor) ELISA Kit
￥4800
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 技术资料
- 供应商：
武汉益普生物科技有限公司
- 检测范围：
0.31-5 μg/mL
- 检测方法：
Colorimetric
- 应用：
Quantitative
- 样本：
Plasma, Serum
- 灵敏度：
0.156 μg/ml
- 规格：
96T
| 产品名 | Daclizumab ELISA Kit |
| 货号 | KDB95803 |
| 别名 | BIIB019, DAC HYP, CAS: 152923-56-3 |
| 规格 | 96T |
| 检测方法 | Colorimetric |
| 样本类型 | Plasma, Serum |
| 实验类型 | Quantitative |
| 检测范围 | 0.31-5 μg/mL |
| 灵敏度 | 0.156 μg/ml |
| 回收率 | 80-120% |
| 稳定性和存储 | The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition. |
| 背景 | Daclizumab (DAC) is a humanized, monoclonal antibody that blocks CD25, a critical element of the high-affinity interleukin-2 receptor (IL-2R). DAC HYP blockade of CD25 inhibits effector T cell activation, regulatory T cell expansion and survival, and activation-induced T-cell apoptosis. Because CD25 blockade reduces IL-2 consumption by effector T cells, it increases IL-2 bioavailability allowing for greater interaction with the intermediate-affinity IL-2R, and therefore drives the expansion of CD56bright natural killer (NK) cells. Furthermore, there appears to be a direct correlation between CD56bright NK cell expansion and DAC HYP efficacy in reducing relapses and MRI evidence of disease activity in patients with RMS in phase II and phase III double-blind, placebo- and active comparator-controlled trials. Therapeutic efficacy was maintained during open-label extension studies. However, treatment was associated with an increased risk of rare adverse events, including cutaneous inflammation, autoimmune hepatitis, central nervous system Drug Reaction with Eosinophilia Systemic Symptoms (DRESS) syndrome, and autoimmune Glial Fibrillary Acidic Protein (GFAP) alpha immunoglobulin-associated encephalitis. As a result, DAC HYP was removed from clinical use in 2018. The lingering importance of DAC is that its use led to a deeper understanding of the underappreciated role of innate immunity in the potential treatment of autoimmune disease. |
| 保存方法 | 2-8 ℃ |
| 说明 | For Research Use Only. |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
技术资料暂无技术资料 索取技术资料
Daclizumab ELISA Kit（ELISA试剂盒）
￥6768
